Clinical trial
Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS
NCT00002181
Study timeline
Registry last updated2005-06-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Herpes Simplexunresolved
HIV Infectionsunresolved
Interventions
CidofovirDRUG · verified · RxNorm: cidofovir
Sponsors & collaborators
Gilead Scienceslead sponsor
Mapped research locations
DallasTexas, United States3New YorkNew York, United States1Los AngelesCalifornia, United States1AtlantaGeorgia, United States1San FranciscoCalifornia, United States1San DiegoCalifornia, United States1AustinTexas, United States1Long BeachCalifornia, United States1UrbanaIllinois, United States1Santa RosaCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00002181 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.